Live Science on MSN

New triple-drug treatment stops pancreatic cancer in its tracks, a mouse study finds

By targeting three key growth pathways at once, researchers eliminated pancreatic tumors in multiple mouse models and ...
Drug Target Review

Drug trio found to block tumour resistance in pancreatic cancer models

Explore groundbreaking research on pancreatic cancer treatment that shows promise in inducing complete tumour regression.
Soap Central

Who is Dr. Mariano Barbacid? Spanish oncologist and his team achieve pancreatic cancer regression after targeted combination therapy

According to CNIO, among the various kinds of cancer, pancreatic cancer remains one of the deadliest and is a widely known ...
Medscape

Elraglusib Improves Survival in Metastatic Pancreatic Cancer

The investigational GSK-3-beta inhibitor elraglusib can extend overall survival when added to standard first-line ...
Labroots

Triple Combination Approach Cures Pancreatic Cancer In Pre-Clinical Models

Pancreatic malignancies remain some of the most challenging cancers to treat.  Experts anticipate over 52,000 pancreatic cancer-related deaths this ye | Cancer ...

Nagourney Cancer Institute Challenges “Death Sentence” Mindset in Stage 4 Pancreatic Cancer

With a 5-year survival of only 3.3% in advanced disease, pancreatic cancer remains one of the most lethal human tumors. But ...
Medscape

Lung-Only Metastases in Pancreatic Cancer Linked to Extended Survival and Unique Patient Profile

A retrospective analysis finds that patients with lung-only metastatic pancreatic cancer have better overall survival, are ...